Stemcells@lunch Digested

Dr Lee Rayfield was educated at the University of Southampton, where he gained a Bachelor of Science (BSc) honours degree in Biology in 1978. He then studied for his Doctor of Philosophy (PhD) degree from St Mary's Hospital Medical School (Paddington, Greater London), being awarded his doctorate in 1981, after which he remained as a post-doctoral researcher until 1984. His final medical post was as a lecturer in immunology at UMDS. In 1991 he began studying for the ministry, and became the Bishop of Swindon, the sole suffragan bishop of the Diocese of Bristol, in 2005.

Dr Robert Knight studied for a PhD in Molecular Evolution at the University of Reading before changing directions and pursuing postdoctoral research in the field of musculoskeletal development at the University of California, Irvine and the University of Sheffield. He moved to King’s College London as a BBSRC David Phillips Fellow in 2007 and his group is focused on the signals that direct the complex behaviour of progenitor cells during development of the vertebrate head. His current focus is to determine how progenitor cells are controlled during tissue regeneration and identify the factors that control them, using in vivo imaging and genetic manipulations. For more info please see ... https://www.kcl.ac.uk/dentistry/research/divisions/craniofac/ResearchGroups/KnightLab/GroupMembers.aspx

Dr Mathis Riehle is a Senior Researcher at the Glasgow University Centre for Cell Engineering investigating the molecular mechanisms of how cells interact with surfaces using devices made by micro- and nanofabrication with a specific chemical, topographic or mechanical surface design. For more information about his work please follow the link... https://www.uofgcce.org/staff

Dr Stephen Patrick is a cell biologist with a focus on molecular imaging. He completed his B.Sc. in Cell Biology at the University of Durham in 2009 and completed his PhD at the University of Cambridge in 2013, working on the development of novel genetic reporters for MRI, SPECT, and Bioluminescence imaging. Stephen is now a research associate at the Centre for Advanced Biomedical Imaging (CABI) at UCL, working on developing in vivo cell tracking techniques for use in stem cells. If you would like to know more visit his webpage https://www.ukrmp.org.uk/hubs/safety/our-research-team/dr-stephen-patrick-university-college-london/

The Klein lab is interested in understanding how organs form in the embryo and how they renew and regenerate in the adult. Their research is centered on understanding how development and regeneration normally occur in the hope of one day treating diseases that result from abnormalities in these processes. If you want to find out more about Ophir and the lab please follow the link to http://klein.ucsf.edu/welcome-klein-lab Speak to you next week!

Helena is interested in the functional effects of genetic variation in human induced pluripotent stem cells (iPSC). Her research combines computational and experimental methods in iPSC-based models to understand the cellular mechanisms that lead to rare human diseases. Helena is a human geneticist who leads a research group at the UCL Great Ormond Street Institute of Child Health. She is a MRC eMedLab career development fellow (www.emedlab.ac.uk) and holds an appointment also at the Wellcome Trust Sanger Institute. Helena received her PhD from the University of Helsinki, where she studied the genetic mechanisms underlying autism spectrum disorders. She then transitioned to functional genomics, using diverse next-generation sequencing -based assays to study how DNA sequence variation influences different levels of gene regulation in human cells, first at the University of Geneva, and then at the EMBL-EBI. She joined the Human Induced Pluripotent Stem Cells Initiative (www.hipsci.org) in 2014 and has since foc

Dr Rosalind Hannen, our today's interviewee at Stem Cells @lunch digested, is a postdoctoral researcher at the Blizard Institute in Queen Mary University of London. For any questions email us at stemcellsatlunch@kcl.ac.uk

Dr Shery Huang's group 'Biointerface', is driven by translational bioengineering research, focusing on 3D bioprinting/ biomicrofabrication, and developing biomimetic organ-on-chips for high throughput drug testing. If you would like to know more visit her webpage:http://www.eng.cam.ac.uk/profiles/yysh2 Happy New Year from all of us at Stem Cells @lunch digested! If you have any questions just email: stemcellsatlunch@kcl.ac.uk

In this episode of Stem Cells @lunch digested we interviewed Thea Stewart, a research Fellow in Metals Analysis and Bioimaging at King's College London. Thea is not only a great scientist but also a talented musician and we have a unique live performance ready for you, our listener, as an early Christmas gift! :)

This week on Stem Cells at Lunch we interviewed Dr Ravi Desai, the scientist behind the Making Lab at The Francis Crick Institute: https://www.crick.ac.uk/research/science-technology-platforms/making-lab/ If you have question or comments, drop as a line on stemcellsatlunch@kcl.ac.uk

"In our world of co-creation, hyper-connectivity and exponentially growing technology, our science industry is in much need of disruption. Our slow processes, our steep barriers to entry, and our poor external and internal communication is eroding trust and discouraging talent. We speak to the innovators, iconoclasts and entrepreneurs intent on creating change in science. We record podcasts, we write editorials, we run events. This is Science: Disrupt." Have a look at https://sciencedisrupt.com and share your thoughts with us using stemcellsatlunch@kcl.ac.uk

In today's episode we interviewed Dr Oliver Baker, the Head of Gene Editing & Embryology Core (GEEC) at King’s College London . In this facility at King’s, he is using crisp technology for gene editing. If you have any comments or questions email us on stemcellsatlunch@kcl.ac.uk

Dr Jonathan Chubb - http://www.ucl.ac.uk/lmcb/users/jonathan-chubb

Francesco Iorio is a senior bioinformatician working with Open Targets: a public-private initiative involving teams at the Wellcome Trust Sanger Institute, the EMBL – European Bioinformatics Institute, GlaxoSmithKline and Biogen, with the mission of exploiting Big Data for systematically identifying new therapeutic targets. Previously he was an ESPOD fellow in joint post-doctoral program between the European Bioinformatics Institute and the Wellcome Trust Sanger Institute under the guidance of Julio Saez-Rodriguez and Mathew Garnett. If you have any comments or questions email us on stemcellsatlunch@kcl.ac.uk

Stem Cells @ Lunch is digested back! In today's episode we interviewed Dr Dinis Calado, a group leader in the Francis Crick Institute. His research aims to elucidate mechanisms by which healthy cells of the haematopoietic system become cancerous, with major focus on B lymphocytes. If you have any comments or questions email us on stemcellsatlunch@kcl.ac.uk

Dr Nathan Benaich is an investor, a technologist and a former scientist. He has done his PhD at the CSCRM and now works with companies that solve challenging and valuable problems using breakthrough technologies including, but not limited to, artificial intelligence.

http://cambridge-stem-cell-institute.appstor.io

Episode 18 - Chris Baker by StemCells@Lunch Digested

Dr Edouard Hanezzo is a postdoctoral researcher with Prof Ben Simons at The University of Cambridge. Their research applies methods of non-equilibrium statistical mechanics and population dynamics to lineage tracing studies to investigate mechanisms of stem cell fate in development and maintenance. If you like this episode leave us a review on iTunes and email us on stemcellsatlunch@kcl.ac.uk

Dr Mathieu Bollen is a Group leader in the Laboratory of Biosignaling & Therapeutics and Chair of Department of Cellular and Molecular Medicine at the University of Leuven, Belgium. In his lab they investigate cellular signal transduction pathways at the molecular level, with the major goal of identifying and developing novel biomarkers or therapeutic targets for human diseases.